Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naïve patients with somatotroph adenomas

Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly

(2011) Stine Lyngvi Fougner et al.   CLINICAL ENDOCRINOLOGY

The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly

(2011) C. N. Jayasena et al.   CLINICAL ENDOCRINOLOGY

Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly

(2011) Ansgar Heck et al.   CLINICAL ENDOCRINOLOGY

Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae

(2010) Yuriz Bakhtiar et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response

(2010) Stine Lyngvi Fougner et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Pathogenesis of Pituitary Tumors

(2009) Sylvia L. Asa et al.   Annual Review of Pathology-Mechanisms of Disease

Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional Form

(2008) Abdulkader Obari et al.   ENDOCRINE PATHOLOGY

A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly

(2008) I M Holdaway et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR

(2008) Giselle F Taboada et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant Growth Hormone-Secreting Adenomas

(2008) Ursula Plöckinger et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM